Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · IEX Real-Time Price · USD
7.09
-0.32 (-4.32%)
At close: Jul 2, 2024, 4:00 PM
7.12
+0.03 (0.42%)
After-hours: Jul 2, 2024, 5:39 PM EDT
Outlook Therapeutics Stock Forecast
OTLK's stock price has decreased by -79.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 8 analysts with 12-month price forecasts for OTLK stock have an average target of 46.43, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 554.87% from the current stock price of 7.09.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 17, 2024.
Analyst Ratings
The average analyst rating for OTLK stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 6 | 6 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +323.13% | May 17, 2024 |
| BTIG | BTIG | Hold → Strong Buy Upgrades $50 | Hold → Strong Buy | Upgrades | $50 | +605.22% | Mar 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $1.5 → $30 | Strong Buy | Maintains | $1.5 → $30 | +323.13% | Mar 25, 2024 |
| Chardan Capital | Chardan Capital | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +746.26% | Feb 15, 2024 |
| Guggenheim | Guggenheim | Hold → Strong Buy Upgrades $40 | Hold → Strong Buy | Upgrades | $40 | +464.17% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
10.58M
EPS This Year
-9.67
from -4.80
EPS Next Year
-2.57
from -9.67
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 16.1M | 76.7M | 358.1M | 602.7M |
| Avg | n/a | 10.6M | 65.0M | 208.6M | 382.4M |
| Low | n/a | 3.7M | 49.5M | 146.4M | 280.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 624.6% | 450.6% | 189.0% |
| Avg | - | - | 514.7% | 220.7% | 83.3% |
| Low | - | - | 368.3% | 125.1% | 34.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -8.02 | -2.21 | -1.67 | 1.28 | 3.38 |
| Avg | -9.67 | -2.57 | -1.62 | 1.24 | 3.28 |
| Low | -11.58 | -3.16 | -1.56 | 1.20 | 3.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 171.7% |
| Avg | - | - | - | - | 163.9% |
| Low | - | - | - | - | 153.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.